Diagnostic accuracy of inflammatory markers for distinguishing malignant and benign ovarian masses
Open Access
- 1 January 2018
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 9 (7) , 1165-1172
Abstract
Objective: To evaluate the role of inflammatory markers for distinguishing malignant and benign ovarian masses.Keywords
This publication has 47 references indexed in Scilit:
- Utility of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios to distinguish malignant from benign ovarian massesJournal of the Turkish-German Gynecological Association, 2016
- Differentiation between benign and malignant ovarian masses in the preoperative period using neutrophil-to-lymphocyte and platelet-to-lymphocyte ratiosMolecular and Clinical Oncology, 2014
- Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancerCancer Chemotherapy and Pharmacology, 2014
- Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancerGynecologic Oncology, 2014
- The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imagingArchives of Gynecology and Obstetrics, 2013
- Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assayGynecologic Oncology, 2013
- Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.2013
- Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation StatementAnnals of Internal Medicine, 2012
- Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphomaHaematologica, 2011
- Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancerClinical and Translational Oncology, 2011